Studies on aging, cancer, and development show that molecular pathways, such as PI3K, and tumor suppressors like p53 and retinoblastoma proteins, display sexual dimorphism and require targeting specific to each sex (Mauvais-Jarvis et al. 2020). The gene discussed is TP53; the disease is cancer.